{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:15:00Z","timestamp":1791846900544,"version":"4.3.4"},"reference-count":127,"publisher":"Centers for Disease Control MMWR Office","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr7002a1","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T10:26:40Z","timestamp":1620296800000},"page":"1-30","source":"Crossref","is-referenced-by-count":201,"title":["Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021"],"prefix":"10.15585","volume":"70","author":[{"given":"Agam K.","family":"Rao","sequence":"first","affiliation":[{"name":"Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sobel","sequence":"additional","affiliation":[{"name":"Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Chatham-Stephens","sequence":"additional","affiliation":[{"name":"Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Luquez","sequence":"additional","affiliation":[{"name":"Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1086\/318134","article-title":"Wound botulism in California, 1951\u20131998: recent epidemic in heroin injectors","volume":"31","author":"Werner","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R2","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management.","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R3","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1086\/444507","article-title":"Botulism.","volume":"41","author":"Sobel","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R4","unstructured":"Smith LD. Botulism. The organism, its toxins, the disease. Springfield, IL: Charles C. Thomas; 1977."},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/infdis\/42.3.209","article-title":"Serum therapy of botulism in monkeys.","volume":"42","author":"Dack","year":"1928","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7883\/yoken1952.23.177","article-title":"Studies of the serum therapy of type E botulism. 3.","volume":"23","author":"Ono","year":"1970","journal-title":"Jpn J Med Sci Biol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R7","unstructured":"Morton HE. The toxicity of\n                      Clostridium botulinum\n                      type A toxin for various species of animals, including man. Philadelphia, PA: Institute for Cooperative Research, University of Pennsylvania; 1961."},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/infdis\/jiv327","article-title":"A novel botulinum neurotoxin, previously reported as serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin.","volume":"213","author":"Maslanka","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R9","doi-asserted-by":"publisher","first-page":"14130","DOI":"10.1038\/ncomms14130","article-title":"Identification and characterization of a novel botulinum neurotoxin.","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chom.2017.12.018","article-title":"Identification of a botulinum neurotoxin-like toxin in a commensal strain of Enterococcus faecium.","volume":"23","author":"Zhang","year":"2018","journal-title":"Cell Host Microbe"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/1873-3468.12969","article-title":"Identification of a novel botulinum neurotoxin gene cluster in Enterococcus.","volume":"592","author":"Brunt","year":"2018","journal-title":"FEBS Lett"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release.","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R13","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/cid\/cix935","article-title":"Clinical characteristics and ancillary test results among patients with botulism\u2014United States, 2002\u20132015","volume":"66","author":"Rao","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R14","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1093\/cid\/cix811","article-title":"Clinical features of foodborne and wound botulism: a systematic review of the literature, 1932\u20132015","volume":"66","author":"Chatham-Stephens","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/toxins10050175","article-title":"Exploiting botulinum neurotoxins for the study of brain physiology and pathology.","volume":"10","author":"Caleo","year":"2018","journal-title":"Toxins (Basel)"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.7326\/0003-4819-95-4-442","article-title":"Clinical features of types A and B food-borne botulism.","volume":"95","author":"Hughes","year":"1981","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/infdis\/166.6.1281","article-title":"Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975\u20131988.","volume":"166","author":"Woodruff","year":"1992","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R18","first-page":"580","article-title":"[Existence of type D botulism in man]","volume":"142","author":"Demarchi","year":"1958","journal-title":"Bull Acad Natl Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R19","first-page":"354","article-title":"[Biological enigma: cat and botulism]","volume":"89","author":"Prevot","year":"1955","journal-title":"Ann Inst Pasteur (Paris)"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R20","first-page":"1489","article-title":"In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.","volume":"280","author":"Coffield","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R21","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S1388-2457(02)00103-7","article-title":"Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting.","volume":"113","author":"Eleopra","year":"2002","journal-title":"Clin Neurophysiol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R22","first-page":"135","article-title":"Clinical and laboratory manifestations of type E botulism in man.","volume":"77","author":"Rogers","year":"1964","journal-title":"Trans Assoc Am Physicians"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R23","first-page":"191","article-title":"Further outbreaks of botulism in Canada.","volume":"84","author":"Dolman","year":"1961","journal-title":"Can Med Assoc J"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R24","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1212\/01.wnl.0000187127.92446.4c","article-title":"Adult botulism type F in the United States, 1981\u20132002.","volume":"65","author":"Gupta","year":"2005","journal-title":"Neurology"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3201\/eid1506.070571","article-title":"Clinical recovery and circulating botulinum toxin type F in adult patient.","volume":"15","author":"Sobel","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/cid\/cix829","article-title":"Making the best of the evidence: toward national clinical guidelines for botulism.","volume":"66","author":"Sobel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R27","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1093\/cid\/cix846","article-title":"The epidemiology of foodborne botulism outbreaks: a systematic review.","volume":"66","author":"Fleck-Derderian","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R28","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1093\/cid\/cix815","article-title":"Efficacy of antitoxin therapy in treating patients with foodborne botulism: a systematic review and meta-analysis of cases, 1923\u20132016.","volume":"66","author":"O\u2019Horo","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R29","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1093\/cid\/cix827","article-title":"Workgroup report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup\u2014Allergic reactions to botulinum antitoxin: a systematic review","volume":"66","author":"Schussler","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R30","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1093\/cid\/cix813","article-title":"Botulism during pregnancy and the postpartum period: a systematic review","volume":"66","author":"Badell","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R31","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1093\/cid\/cix812","article-title":"Pediatric botulism and use of equine botulinum antitoxin in children: a systematic review","volume":"66","author":"Griese","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R32","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1093\/cid\/cix818","article-title":"Type F infant botulism: investigation of recent clusters and overview of this exceedingly rare disease","volume":"66","author":"Halpin","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R33","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1093\/cid\/cix828","article-title":"A case of localized, unilateral (cephalic) wound botulism","volume":"66","author":"Jacobs Slifka","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R34","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1093\/cid\/cix847","article-title":"A case of adult intestinal toxemia botulism during prolonged hospitalization in an allogeneic hematopoietic cell transplant recipient","volume":"66","author":"Parameswaran","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R35","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1093\/cid\/cix817","article-title":"Outbreak of foodborne botulism in an immigrant community: Overcoming delayed disease recognition, ambiguous epidemiologic links, and cultural barriers to identify the cause","volume":"66","author":"Harvey","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R36","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1093\/cid\/cix814","article-title":"Clinical criteria to trigger suspicion for botulism: an evidence-based tool to facilitate timely recognition of suspected cases during sporadic events and outbreaks","volume":"66","author":"Rao","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R37","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1093\/cid\/cix816","article-title":"Safety and improved clinical outcomes in patients treated with new equine-derived heptavalent botulinum antitoxin","volume":"66","author":"Yu","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R38","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1093\/cid\/cix936","article-title":"Outbreak of botulism due to illicit prison-brewed alcohol: public health response to a serious and recurrent problem","volume":"66","author":"Rao","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R39","unstructured":"Committee on Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations; Institute of Medicine. Crisis standards of care: a systems framework for catastrophic disaster response. National Academies Press: Washington, DC; 2012. 24830057"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R40","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1097\/DMP.0b013e31819f1ae2","article-title":"Refining surge capacity: conventional, contingency, and crisis capacity.","volume":"3","author":"Hick","year":"2009","journal-title":"Disaster Med Public Health Prep"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R41","unstructured":"Institute of Medicine. Crisis standards of care: a toolkit for indicators and triggers. Washington, DC: National Academies Press; 2013. https:\/\/www.nap.edu\/read\/18338\/chapter\/3"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","article-title":"Botulism in the United States: a clinical and epidemiologic review.","volume":"129","author":"Shapiro","year":"1998","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R43","article-title":"Botulism","author":"Maslanka","year":"2015"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R44","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1086\/592574","article-title":"International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice.","volume":"47","author":"Sheth","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R45","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1086\/599030","article-title":"Diagnosis and treatment of botulism: a century later, clinical suspicion remains the cornerstone.","volume":"48","author":"Sobel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.7326\/0003-4819-108-3-363","article-title":"Botulism from chopped garlic: delayed recognition of a major outbreak.","volume":"108","author":"St Louis","year":"1988","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3201\/eid1801.110471","article-title":"Asymmetric type F botulism with cranial nerve demyelination.","volume":"18","author":"Filozov","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria.","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R49","doi-asserted-by":"publisher","first-page":"ii23","DOI":"10.1136\/jnnp.2005.069138","article-title":"Nerve conduction studies: essentials and pitfalls in practice.","volume":"76","author":"Mallik","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R50","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/1097-4598(200007)23:7<1137::AID-MUS21>3.0.CO;2-7","article-title":"AAEM case report 16. Botulism.","volume":"23","author":"Maselli","year":"2000","journal-title":"Muscle Nerve"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R51","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1284::AID-MUS11>3.0.CO;2-3","article-title":"Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic study.","volume":"20","author":"Maselli","year":"1997","journal-title":"Muscle Nerve"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R52","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/(SICI)1097-4598(199910)22:10<1388::AID-MUS8>3.0.CO;2-3","article-title":"Neurophysiological assessment in the diagnosis of botulism: usefulness of single-fiber EMG.","volume":"22","author":"Padua","year":"1999","journal-title":"Muscle Nerve"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.15585\/mmwr.mm6429a6","article-title":"Large outbreak of botulism associated with a church potluck meal\u2014Ohio, 2015.","volume":"64","author":"McCarty","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R54","doi-asserted-by":"crossref","unstructured":"Maslanka SE, Solomon HM, Sharma S, Johnson EA. Chapter 32.\n                      Clostridium botulinum\n                      and its toxins. In: Salfinger Y, Tortorello ML, eds. Compendium of methods for the microbiological examination of foods: Washington, DC: American Public Health Association Press; 2013.","DOI":"10.2105\/MBEF.0222.037"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R55","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3390\/toxins7051765","article-title":"Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples.","volume":"7","author":"Kalb","year":"2015","journal-title":"Toxins (Basel)"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R56","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/GRF.0b013e3181deb3f1","article-title":"Acute respiratory failure in pregnancy.","volume":"53","author":"Mighty","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R57","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1378\/chest.120.2.562","article-title":"Clinical predictors of respiratory failure and long-term outcome in black tar heroin-associated wound botulism.","volume":"120","author":"Sandrock","year":"2001","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R58","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4269\/ajtmh.2007.77.386","article-title":"Signs and symptoms predictive of respiratory failure in patients with foodborne botulism in Thailand.","volume":"77","author":"Wongtanate","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R59","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/archneur.58.6.893","article-title":"Anticipating mechanical ventilation in Guillain-Barr\u00e9 syndrome.","volume":"58","author":"Lawn","year":"2001","journal-title":"Arch Neurol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1164\/ajrccm.159.1.9804052","article-title":"Sniff nasal inspiratory pressure. Reference values in Caucasian children.","volume":"159","author":"Stefanutti","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R61","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/thx.50.4.371","article-title":"Maximal values of sniff nasal inspiratory pressure in healthy subjects.","volume":"50","author":"Uldry","year":"1995","journal-title":"Thorax"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R62","doi-asserted-by":"publisher","first-page":"1801214","DOI":"10.1183\/13993003.01214-2018","article-title":"ERS statement on respiratory muscle testing at rest and during exercise.","volume":"53","author":"Laveneziana","year":"2019","journal-title":"Eur Respir J"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R63","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1164\/ajrccm.150.6.7952632","article-title":"Sniff nasal inspiratory pressure. A noninvasive assessment of inspiratory muscle strength.","volume":"150","author":"H\u00e9ritier","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R64","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mus.24929","article-title":"Correlation of single-breath count test and neck flexor muscle strength with spirometry in myasthenia gravis.","volume":"53","author":"Elsheikh","year":"2016","journal-title":"Muscle Nerve"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/1941875210396379","article-title":"Inpatient management of Guillain-Barr\u00e9 syndrome.","volume":"1","author":"Harms","year":"2011","journal-title":"Neurohospitalist"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/pn.2008.152611","article-title":"Neuromuscular disease and respiratory failure.","volume":"8","author":"Hutchinson","year":"2008","journal-title":"Pract Neurol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R67","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/jnnp.56.4.334","article-title":"Acute neuromuscular respiratory paralysis.","volume":"56","author":"Hughes","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000067023","article-title":"Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis.","volume":"49","author":"Dressler","year":"2003","journal-title":"Eur Neurol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-1331.2006.01648.x","article-title":"The structure and mode of action of different botulinum toxins.","volume":"13","author":"Dolly","year":"2006","journal-title":"Eur J Neurol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R70","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1212\/WNL.25.2.150","article-title":"Autonomic dysfunction in botulism B: a clinical report.","volume":"25","author":"Jenzer","year":"1975","journal-title":"Neurology"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R71","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0002-9343(67)90020-4","article-title":"Type B botulism in man.","volume":"42","author":"Koenig","year":"1967","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R72","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10286-003-0118-2","article-title":"Botulism type B presenting as pure autonomic dysfunction.","volume":"13","author":"Merz","year":"2003","journal-title":"Clin Auton Res"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R73","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/1756-0500-6-438","article-title":"Long lasting dysautonomia due to botulinum toxin B poisoning: clinical-laboratory follow up and difficulties in initial diagnosis.","volume":"6","author":"Potulska-Chromik","year":"2013","journal-title":"BMC Res Notes"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R74","doi-asserted-by":"crossref","unstructured":"Truax BT, ed. Autonomic disturbances in the Guillain-Barr\u00e9 syndrome. Seminars in Neurology; 1984: Thieme Medical Publishers, Inc.","DOI":"10.1055\/s-2008-1041579"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R75","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/archneur.1988.00520250125034","article-title":"Cardiovascular autonomic dysfunction in Guillain-Barr\u00e9 syndrome. Therapeutic implications of Swan-Ganz monitoring.","volume":"45","author":"Dalos","year":"1988","journal-title":"Arch Neurol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R76","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00003246-199303000-00023","article-title":"Intensive management and treatment of severe Guillain-Barr\u00e9 syndrome.","volume":"21","author":"Hund","year":"1993","journal-title":"Crit Care Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R77","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain-Barr\u00e9 syndrome.","volume":"62","author":"Hughes","year":"2005","journal-title":"Arch Neurol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R78","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1212\/CON.0000000000000218","article-title":"Acute neuromuscular respiratory failure.","volume":"21","author":"Rabinstein","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R79","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1378\/chest.103.1.170","article-title":"Spirometry and maximal respiratory pressures in patients with facial paralysis.","volume":"103","author":"Fiz","year":"1993","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R80","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/archneurol.2010.207","article-title":"Causes and outcomes of acute neuromuscular respiratory failure.","volume":"67","author":"Cabrera Serrano","year":"2010","journal-title":"Arch Neurol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R81","first-page":"255","article-title":"Practical approach to management of respiratory complications in neurological disorders.","volume":"5","author":"Mangera","year":"2012","journal-title":"Int J Gen Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R82","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1093\/cid\/cix815","article-title":"Efficacy of antitoxin therapy in treating patients with foodborne botulism: a systematic review and meta-analysis of cases, 1923\u20132016.","volume":"66","author":"O\u2019Horo","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R83","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/0002-9343(84)90988-4","article-title":"Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.","volume":"76","author":"Tacket","year":"1984","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R84","unstructured":"Botulism antitoxin heptavalent. (A, B, C, D, E, F, G)\u2014(Equine) [package insert]. Gaithersburg, MD: Cangene Corporation (as Emergent Biosolutions); 2017. https:\/\/www.fda.gov\/media\/85514\/download"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R85","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity reactions associated with botulinal antitoxin.","volume":"69","author":"Black","year":"1980","journal-title":"Am J Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R86","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1086\/508176","article-title":"An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure.","volume":"43","author":"Kongsaengdao","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R87","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/infdis\/150.3.407","article-title":"Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E.","volume":"150","author":"Hatheway","year":"1984","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R88","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1056\/NEJMoa051926","article-title":"Human botulism immune globulin for the treatment of infant botulism.","volume":"354","author":"Arnon","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R89","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/bja\/78.5.601","article-title":"Calculation of drug dosage and body surface area of children.","volume":"78","author":"Lack","year":"1997","journal-title":"Br J Anaesth"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R90","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijid.2014.10.008","article-title":"Two-family outbreak of botulism associated with the consumption of smoked ribs in Sichuan Province, China.","volume":"30","author":"Feng","year":"2015","journal-title":"Int J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R91","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0196-0644(95)70214-8","article-title":"Adsorption of botulinum toxin to activated charcoal with a mouse bioassay.","volume":"25","author":"Gomez","year":"1995","journal-title":"Ann Emerg Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R92","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/01.pec.0000136064.14704.d1","article-title":"Activated charcoal administration in a pediatric emergency department.","volume":"20","author":"Osterhoudt","year":"2004","journal-title":"Pediatr Emerg Care"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R93","doi-asserted-by":"publisher","first-page":"e12416","DOI":"10.1371\/journal.pone.0012416","article-title":"Characterization of botulinum neurotoxin type A neutralizing monoclonal antibodies and influence of their half-lives on therapeutic activity.","volume":"5","author":"Mazuet","year":"2010","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R94","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJM196804252781704","article-title":"Botulism and guanidine.","volume":"278","author":"Cherington","year":"1968","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R95","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1056\/NEJM197001222820405","article-title":"Treatment of botulism with guanidine. Early neurophysiologic studies.","volume":"282","author":"Cherington","year":"1970","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R96","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1001\/jama.1978.03290210058027","article-title":"Botulism and guanidine. Ten years later.","volume":"240","author":"Puggiari","year":"1978","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R97","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ana.410060117","article-title":"Botulism, type A, and treatment with guanidine.","volume":"6","author":"Kaplan","year":"1979","journal-title":"Ann Neurol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R98","first-page":"379","article-title":"Human type A botulism and treatment with 3,4-diaminopyridine.","volume":"32","author":"Davis","year":"1992","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R99","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1056\/NEJM197109302851404","article-title":"Failure of guanidine therapy in botulism A.","volume":"285","author":"Faich","year":"1971","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R100","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1001\/archinte.135.5.726","article-title":"Guanidine in type B botulism.","volume":"135","author":"Oh","year":"1975","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R101","first-page":"473","article-title":"Human botulism caused by Clostridium botulinum type E: the Birmingham outbreak.","volume":"48","author":"Ball","year":"1979","journal-title":"Q J Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R102","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5694\/j.1326-5377.1992.tb137135.x","article-title":"Severe botulism after eating home-preserved asparagus.","volume":"157","author":"Paterson","year":"1992","journal-title":"Med J Aust"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R103","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1345\/aph.1C034","article-title":"Management of botulism.","volume":"37","author":"Robinson","year":"2003","journal-title":"Ann Pharmacother"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R104","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1128\/AEM.48.5.951-955.1984","article-title":"Acute toxicity of aminoglycoside antibiotics as an aid in detecting botulism.","volume":"48","author":"Wang","year":"1984","journal-title":"Appl Environ Microbiol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R105","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/mus.880100514","article-title":"Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin.","volume":"10","author":"Molg\u00f3","year":"1987","journal-title":"Muscle Nerve"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R106","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0022-3476(79)80314-5","article-title":"Potentiation of neuromuscular weakness in infant botulism by aminoglycosides.","volume":"95","author":"L\u2019Hommedieu","year":"1979","journal-title":"J Pediatr"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R107","first-page":"45","article-title":"Neuromuscular blocking activity of aminoglycoside antibiotics.","volume":"2","author":"Paradelis","year":"1980","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R108","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1542\/peds.68.1.50","article-title":"Potentiation of Clostridium botulinum toxin aminoglycoside antibiotics: clinical and laboratory observations.","volume":"68","author":"Santos","year":"1981","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R109","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4097\/kjae.2013.64.2.143","article-title":"The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade.","volume":"64","author":"Lee","year":"2013","journal-title":"Korean J Anesthesiol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R110","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4097\/kjae.2015.68.1.50","article-title":"The effect of high concentration of magnesium with ropivacaine, gentamicin, rocuronium, and their combination on neuromuscular blockade.","volume":"68","author":"Rhee","year":"2015","journal-title":"Korean J Anesthesiol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R111","doi-asserted-by":"crossref","unstructured":"Pandian SJ, Subramanian M, Vijayakumar G, Balasubramaniam GA, Sukumar K. Therapeutic management of botulism in dairy cattle. Vet World 2015;8:1305\u20139.","DOI":"10.14202\/vetworld.2015.1305-1309"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R112","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0014-2999(86)90556-X","article-title":"Effects of calcium channel blockers on neuromuscular blockade induced by aminoglycoside antibiotics.","volume":"128","author":"Del Pozo","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R113","first-page":"687","article-title":"Interaction of aminoglycoside antibiotics and calcium channel blockers at the neuromuscular junctions.","volume":"10","author":"Paradelis","year":"1988","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R114","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0041-008X(68)90037-9","article-title":"The interaction between 5-hydroxytryptamine and botulinum toxin type A.","volume":"12","author":"Simpson","year":"1968","journal-title":"Toxicol Appl Pharmacol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R115","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/01.grf.0000135653.56778.3f","article-title":"Maternal medications during breastfeeding.","volume":"47","author":"Hale","year":"2004","journal-title":"Clin Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R116","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action.","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R117","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJM197802092980620","article-title":"Botulism and breast milk.","volume":"298","author":"Middaugh","year":"1978","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R118","unstructured":"Jim J, Johnson B, Millerburg T, Silver T, Funk D, Bixby M. Type A botulism in Alaska. State of Alaska Epidemiology Bulletin. 1976;13."},{"issue":"2","key":"key-10.15585\/mmwr.rr7002a1-202105061025-R119","first-page":"51","article-title":"An outbreak of botulism in Tucumcari, New Mexico.","author":"Douthirt","year":"1938","journal-title":"Southwest Med"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R120","first-page":"106","article-title":"Botulism\u2014California.","volume":"21","author":"CDC","year":"1972","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R121","first-page":"400","article-title":"Notes from the field: infant botulism caused by Clostridium baratii type F\u2014Iowa, 2013.","volume":"64","author":"Moodley","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R122","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1086\/651091","article-title":"Guideline for prevention of catheter-associated urinary tract infections 2009.","volume":"31","author":"Gould","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R123","unstructured":"Berlowitz D, VanDeusen Lukas C, Parker V, Niederhauser A, Silver J, Logan C, Preventing pressure ulcers in hospitals. Rockville, MD: Agency for Healthcare Research and Quality; 2014. https:\/\/www.ahrq.gov\/sites\/default\/files\/publications\/files\/putoolkit.pdf"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R124","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1086\/677144","article-title":"Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update.","volume":"35","author":"Klompas","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R125","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1504\/TBJ.2009.031683","article-title":"Reflections on the care of a patient severely poisoned by \u2018rogue\u2019 botulinum toxin and rendered paralysed for a protracted hospital stay.","volume":"1","author":"Marcus","year":"2009","journal-title":"Botulinum J"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R126","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s13054-016-1483-2","article-title":"Communicating with conscious and mechanically ventilated critically ill patients: a systematic review.","volume":"20","author":"ten Hoorn","year":"2016","journal-title":"Crit Care"},{"key":"key-10.15585\/mmwr.rr7002a1-202105061025-R127","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0022-3999(86)90009-7","article-title":"Botulism: emotional impact on patient and family.","volume":"30","author":"Cohen","year":"1986","journal-title":"J Psychosom Res"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T09:16:37Z","timestamp":1672046197000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/70\/rr\/rr7002a1.htm?s_cid=rr7002a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":127,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,5,7]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr7002a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,7]]},"published":{"date-parts":[[2021,5,7]]}}}